S
24.77
-0.73 (-2.88%)
| Previous Close | 25.51 |
| Open | 25.51 |
| Volume | 2,376,792 |
| Avg. Volume (3M) | 879,003 |
| Market Cap | 3,148,861,440 |
| Price / Earnings (Forward) | 20.20 |
| Price / Sales | 0.900 |
| Price / Book | 1.42 |
| 52 Weeks Range |
| Profit Margin | -2.03% |
| Operating Margin (TTM) | 13.02% |
| Diluted EPS (TTM) | -0.470 |
| Quarterly Revenue Growth (YOY) | 14.30% |
| Total Debt/Equity (MRQ) | 99.38% |
| Current Ratio (MRQ) | 1.80 |
| Operating Cash Flow (TTM) | 251.30 M |
| Levered Free Cash Flow (TTM) | 135.80 M |
| Return on Assets (TTM) | 3.90% |
| Return on Equity (TTM) | 3.08% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Medical Care Facilities (US) | Mixed | Mixed |
| Medical Care Facilities (Global) | Mixed | Mixed | |
| Stock | Surgery Partners, Inc. | Bearish | Bearish |
AIStockmoo Score
2.1
| Analyst Consensus | 4.0 |
| Insider Activity | NA |
| Price Volatility | 4.5 |
| Technical Moving Averages | 2.5 |
| Technical Oscillators | -2.5 |
| Average | 2.13 |
|
Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It operates in two segments: Surgical Facility Services and Ancillary Services out of which the Surgical Facility Services segment accounts for the majority of revenue. |
|
| Sector | Healthcare |
| Industry | Medical Care Facilities |
| Investment Style | Small Growth |
| % Held by Insiders | 1.13% |
| % Held by Institutions | 110.09% |
| 52 Weeks Range | ||
| Price Target Range | ||
| High | 43.00 (Cantor Fitzgerald, 73.60%) | Buy |
| Median | 35.00 (41.30%) | |
| Low | 28.00 (JP Morgan, 13.04%) | Hold |
| Average | 35.60 (43.72%) | |
| Total | 4 Buy, 1 Hold | |
| Avg. Price @ Call | 26.23 | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| JP Morgan | 03 Dec 2024 | 28.00 (13.04%) | Hold | 23.00 |
| RBC Capital | 20 Nov 2024 | 35.00 (41.30%) | Buy | 22.51 |
| Macquarie | 19 Nov 2024 | 34.00 (37.26%) | Buy | 22.75 |
| 13 Nov 2024 | 34.00 (37.26%) | Buy | 25.51 | |
| UBS | 14 Oct 2024 | 38.00 (53.41%) | Buy | 31.75 |
| Cantor Fitzgerald | 04 Oct 2024 | 43.00 (73.60%) | Buy | 31.16 |
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| EVANS JASON ERIC | - | - | 0 | 0 |
| Aggregate Net Quantity | 0 | |||
| Aggregate Net Value ($) | 0 | |||
| Aggregate Avg. Buy ($) | - | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| EVANS JASON ERIC | Officer | 12 Dec 2024 | Option execute | 16,500 | - | - |
| Date | Type | Details |
|---|---|---|
| 12 Nov 2024 | Announcement | Surgery Partners, Inc. Announces Third Quarter 2024 Results |
| 21 Oct 2024 | Announcement | Surgery Partners, Inc. Announces Third Quarter 2024 Earnings Release Date and Conference Call Details |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |